News | October 08, 2021
CDSCO approves Syntellix implants
This opens up a huge market for the company’s Magnezis implants in India
This opens up a huge market for the company’s Magnezis implants in India
The company plans to expand its portfolio in regulated markets aggressively
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
The platform will provide a safe and nurturing space for women, and non-binary individuals
The applications navigate through more than 100 workflows across biotech, pharma, healthcare, food, forensics, industrial and applied sciences industries
The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
_256_384.jpg)
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
Subscribe To Our Newsletter & Stay Updated
